
What is it?
7-KETO (3-acetyl-7-oxo-dehydroepiandrosterone) is a naturally occurring metabolite
(breakdown product) of the hormone dehydroepiandrosterone (DHEA).1 DHEA is the most abundant of the
adrenal steroid hormones and serves as a precursor for sex hormones, such as oestrogen and testosterone.
7-KETO was developed by researchers who were looking for biologically active metabolites of
DHEA that could not be converted to the potentially cancer-causing sex steroids (e.g.,
oestrogen and testosterone).
Tests in animals and test tubes were performed in the areas of immune modulation, memory
enhancement, and thermogenesis (the process the body uses to convert stored calories into
energy). In all cases, the effects of 7-KETO were stronger than those produced by
DHEA.2 3 4 5
The capacity of 7-KETO to promote weight
loss in overweight people been investigated in a double-blind study.6
Participants in the study were advised to exercise three times per week for 45 minutes and to
eat an 1,800-calorie per day diet. Each person was given either a placebo or 100 mg of 7-KETO
twice daily. After eight weeks, those receiving 7-KETO had lost an average of 6.34 pounds,
compared with 2.13 pounds in the placebo group (a statistically significant difference). In
addition, the percentage of body fat decreased by 1.8% in the 7-KETO group, compared with only
0.57% in the placebo group. The increased weight loss in the 7-KETO group was associated with
a significant increase in levels of T3 (a thyroid hormone that plays a major role in
determining a person’s metabolic rate), although the levels of T3 did not exceed the
normal range.
Where is it found?
7-KETO is available as a dietary supplement.
7-KETO has been used in
connection with the following conditions (refer to the individual
health concern for complete information):
Who is likely to be deficient?
Since the level of 7-KETO is directly related to the level of DHEA in the body,7 people with lower DHEA
levels likely have low 7-KETO levels as well. Low DHEA levels are primarily associated with
aging.
How much is usually taken?
The manufacturer of 7-KETO recommends 100 mg twice daily for weight loss.
Are there any side effects or interactions?
A safety study in humans has shown that 7-KETO did not raise oestrogen or testosterone
levels or produce any other negative effects at levels up to 200 mg per day for eight
weeks.8 Short-term animal studies also revealed no adverse effects with large
amounts of 7-KETO.9 10 11 However, the long-term safety of
7-KETO for humans has not been demonstrated, and, because it is chemically related to steroid
hormones, the potential for adverse effects must be considered. In addition, the increase in
T3 levels resulting from taking 7-KETO could, in theory, produce adverse effects on the heart
or promote bone loss. For these reasons, people wishing to take 7-KETO, particularly those who
have a thyroid disorder or are taking thyroid
hormone, should consult a physician.
At the time of writing, there were no well-known drug interactions
with 7-KETO.
References
(To view, roll mouse over heading; to hide, click on heading)
1. Lardy H, Kneer N, Wei Y, et al. Ergosteroids. II: Biologically active
metabolites and synthetic derivatives of dehydroepiandrosterone. Steroids
1998;63:158-65.
2. Shi J, Lardy H. 3β-Hydroxyandrost-5-ene-7,17-dione (7-keto-DHEA)
improves memory in mice. FASEB J 1998;12:A4427.
3. Reich IL, Lardy H, Wei Y, et al. Ergosteroids III. Syntheses and
biological activity of seco-steroids related to dehydroepiandrosterone. Steroids
1998;63:542-53.
4. Lardy H, Kneer N, Wei Y, et al. Ergosteroids. II: Biologically active
metabolites and synthetic derivatives of dehydroepiandrosterone. Steroids
1998;63:158-65.
5. Bobyleva V, Bellei M, Kneer N, Lardy H. The effects of the ergosteroid
7-oxo-dehydroepiandrosterone on mitochondrial membrane potential: possible relationship to
thermogenesis. Arch Biochem Biophys 1997;341:122-8.
6. Colker CM, Torina GC, Swain MA, Kalman DS. Double-blind study
evaluating the effects of exercise plus 3-acetyl-7-oxo-dehydroepiandrosterone on body
composition and the endocrine system in overweight adults. J Exercise Physiology
Online 1999;2(4).
7. Lardy H, Kneer N, Wei Y, et al. Ergosteroids. II: Biologically active
metabolites and synthetic derivatives of dehydroepiandrosterone. Steroids
1998;63:158–65.
8. Davidson MH, Weeks CE, Lardy H, et al. Safety and endocrine effects of
3-acetyl-7-oxo DHEA (7-keto DHEA). FASEB J 1998;12:A4429.
9. Lardy H, Henwood SM, Weeks CE. An acute oral gavage study of
3beta-acetoxyandrost- 5-ene-7,17-dione (7-oxo-DHEA-acetate) in rats. Biochem Biophys Res
Commun 1999;254:120–3.
10. Henwood SM, Weeks CE, Lardy H. An escalating dose oral gavage study
of 3beta-acetoxyandrost-5-ene-7, 17-dione (7-oxo-DHEA-acetate) in rhesus monkeys. Biochem
Biophys Res Commun 1999;254:124–6.
11. Weeks C, Lardy H, Henwood S. Preclinical toxicology evaluation of
3-acetyl-7-oxo-dehydroepiandrosterone (7-keto DHEA). FASEB J 1998;12:A4428.
Copyright © 2006 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the
company.
Learn more about the authors of
Healthnotes.
The information presented in Healthnotes is for informational purposes
only. It is based on scientific studies (human, animal, or in vitro), clinical
experience, or traditional usage as cited in each article. The results reported may not
necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over the counter medication is also available. Consult your doctor,
practitioner, and/or chemist for any health problem and before using any supplements or before
making any changes in prescribed medications. Information expires March 2007.